Intraocular Melanoma
📧 Sign up to get email alerts when something new happens for Intraocular Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma [Phase 2]
Phase 2 clinical trial update evaluating sunitinib malate or valproic acid to prevent metastasis in high-risk uveal melanoma.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]
Phase 2 clinical trial update for a vaccine therapy in metastatic melanoma of the eye (intraocular/extrasocular extension), completed.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma [Phase 2]
Phase 2 trial update evaluating monoclonal antibody therapy and vaccine therapy in patients with resected stage III or stage IV melanoma; re…
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma [Phase 3]
Phase 3 trial comparing hepatic arterial infusion with melphalan to standard therapy in unresectable liver metastases due to melanoma comple…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance [Phase 2]
Phase 2 clinical trial evaluating dacarbazine plus recombinant interferon alfa-2b in patients with primary uveal melanoma with genetic imbal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating axitinib for metastatic or unresectable melanoma (including intraocular melanoma) has been terminated. Results ha…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial of a vaccine therapy for recurrent stage III/IV melanoma not removable by surgery has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 1]
Phase 1 trial evaluating a vaccine therapy for advanced melanoma (stages IIB/IIC/III/IV) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases [EARLY_Phase 1]
Early-phase 1 trial evaluating the combination of radioembolization with ipilimumab for uveal melanoma with liver metastases has been termin…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel) for metastatic intraocular melanom…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]
Phase 2 trial update for cixutumumab in metastatic intraocular melanoma (ciliary body/choroid, iris) completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating AZD2171 for recurrent or Stage IV melanoma has completed enrollment with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial results are reported for aflibercept (VEGF Trap) in patients with unresectable recurrent melanoma (Stage III or Stage IV), wit…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
This clinical trial update describes a study that collected tumor samples from patients with primary intraocular melanoma undergoing radiati…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
This Phase 2 trial evaluating a vaccine therapy for unresectable stage III/IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma [Phase 1, Phase 2]
Completed Phase 1/2 trial testing a vaccine therapy in patients with advanced melanoma, including skin melanoma and intraocular melanoma.
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma [Phase 2]
A Phase 2 trial of vorinostat in patients with metastatic or unresectable melanoma has completed, with results posted in 2014. The study enc…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [Phase 1]
Phase 1 trial evaluating Indium-111 pentetreotide in patients with refractory cancer across multiple tumor types. The study status is termin…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
This Phase 2 trial evaluates a vaccine therapy with or without interleukin-12 in patients with stage III/IV melanoma, including intraocular …
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [Phase 1]
A Phase 1 trial evaluated a monoclonal antibody and vaccine therapy in patients with stage III or stage IV melanoma that had been surgically…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma [Phase 2]
A Phase 2 vaccine therapy trial in melanoma patients with Stage IIC to IV disease has completed. The trial encompassed intraocular subtypes …
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1]
This Phase 1 trial evaluates a vaccine therapy in patients with stage III or stage IV melanoma, including intraocular melanoma and cutaneous…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating vaccine therapy with interleukin-12 after surgery in melanoma patients, using either alum (alumin…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial of a vaccine therapy for metastatic melanoma has completed, including patients with intraocular melanoma and cutaneous melan…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a combination of sunitinib, tamoxifen, and cisplatin for high-risk intraocular melanoma.